Literature DB >> 25371179

Rapid childhood T-ALL growth in xenograft models correlates with mature phenotype and NF-κB pathway activation but not with poor prognosis.

S Poglio1, X Cahu1, B Uzan1, C Besnard-Guérin2, H Lapillonne3, T Leblanc4, A Baruchel4, J Landman-Parker3, A Petit3, F Baleydier5, S Amsellem6, V Baud2, P Ballerini7, F Pflumio1.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 25371179     DOI： 10.1038/leu.2014.317

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  13 in total

1.  Expression of CD34 and CD7 on human T-cell acute lymphoblastic leukemia discriminates functionally heterogeneous cell populations.

Authors:  B Gerby; E Clappier; F Armstrong; C Deswarte; J Calvo; S Poglio; J Soulier; N Boissel; T Leblanc; A Baruchel; J Landman-Parker; P H Roméo; P Ballerini; F Pflumio
Journal:  Leukemia       Date:  2011-05-13       Impact factor: 11.528

2.  Growth of human T-cell lineage acute leukemia in severe combined immunodeficiency (SCID) mice and non-obese diabetic SCID mice.

Authors:  J P Steele; R D Clutterbuck; R L Powles; P L Mitchell; C Horton; R Morilla; D Catovsky; J L Millar
Journal:  Blood       Date:  1997-09-01       Impact factor: 22.113

3.  Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Authors:  Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-30       Impact factor: 11.205

4.  Early relapse in ALL is identified by time to leukemia in NOD/SCID mice and is characterized by a gene signature involving survival pathways.

Authors:  Lüder Hinrich Meyer; Sarah Mirjam Eckhoff; Manon Queudeville; Johann Michael Kraus; Marco Giordan; Jana Stursberg; Andrea Zangrando; Elena Vendramini; Anja Möricke; Martin Zimmermann; Andre Schrauder; Georgia Lahr; Karlheinz Holzmann; Martin Schrappe; Giuseppe Basso; Karsten Stahnke; Hans Armin Kestler; Geertruy Te Kronnie; Klaus-Michael Debatin
Journal:  Cancer Cell       Date:  2011-02-03       Impact factor: 31.743

5.  Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction.

Authors:  K A Fitzgerald; E M Palsson-McDermott; A G Bowie; C A Jefferies; A S Mansell; G Brady; E Brint; A Dunne; P Gray; M T Harte; D McMurray; D E Smith; J E Sims; T A Bird; L A O'Neill
Journal:  Nature       Date:  2001-09-06       Impact factor: 49.962

6.  Bay 11-7082 inhibits transcription factor NF-kappaB and induces apoptosis of HTLV-I-infected T-cell lines and primary adult T-cell leukemia cells.

Authors:  Naoki Mori; Yasuaki Yamada; Shuichi Ikeda; Yoshihiro Yamasaki; Kunihiro Tsukasaki; Yuetsu Tanaka; Masao Tomonaga; Naoki Yamamoto; Masahiro Fujii
Journal:  Blood       Date:  2002-09-01       Impact factor: 22.113

7.  Clinical significance of HOX11L2 expression linked to t(5;14)(q35;q32), of HOX11 expression, and of SIL-TAL fusion in childhood T-cell malignancies: results of EORTC studies 58881 and 58951.

Authors:  Hélène Cavé; Stefan Suciu; Claude Preudhomme; Bruce Poppe; Alain Robert; Anne Uyttebroeck; Michèle Malet; Patrick Boutard; Yves Benoit; Laurent Mauvieux; Patrick Lutz; Françoise Méchinaud; Nathalie Grardel; Francoise Mazingue; Madeleine Dupont; Geneviève Margueritte; Marie-Pierre Pages; Yves Bertrand; Emmanuel Plouvier; Ghislaine Brunie; Christian Bastard; Dominique Plantaz; Isabel Vande Velde; Anne Hagemeijer; Frank Speleman; Michel Lessard; Jacques Otten; Etienne Vilmer; Nicole Dastugue
Journal:  Blood       Date:  2003-09-22       Impact factor: 22.113

8.  The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins.

Authors:  Marc Veldhoen; Keiji Hirota; Astrid M Westendorf; Jan Buer; Laure Dumoutier; Jean-Christophe Renauld; Brigitta Stockinger
Journal:  Nature       Date:  2008-03-23       Impact factor: 49.962

9.  The Notch/Hes1 pathway sustains NF-κB activation through CYLD repression in T cell leukemia.

Authors:  Lluis Espinosa; Severine Cathelin; Teresa D'Altri; Thomas Trimarchi; Alexander Statnikov; Jordi Guiu; Veronica Rodilla; Julia Inglés-Esteve; Josep Nomdedeu; Beatriz Bellosillo; Carles Besses; Omar Abdel-Wahab; Nicole Kucine; Shao-Cong Sun; Guangchan Song; Charles C Mullighan; Ross L Levine; Klaus Rajewsky; Iannis Aifantis; Anna Bigas
Journal:  Cancer Cell       Date:  2010-09-14       Impact factor: 31.743

10.  AML engraftment in the NOD/SCID assay reflects the outcome of AML: implications for our understanding of the heterogeneity of AML.

Authors:  Daniel J Pearce; David Taussig; Kazem Zibara; Lan-Lan Smith; Christopher M Ridler; Claude Preudhomme; Bryan D Young; Ama Z Rohatiner; T Andrew Lister; Dominique Bonnet
Journal:  Blood       Date:  2005-10-18       Impact factor: 22.113
View more
  7 in total

1.  Bone marrow sites differently imprint dormancy and chemoresistance to T-cell acute lymphoblastic leukemia.

Authors:  Xavier Cahu; Julien Calvo; Sandrine Poglio; Nais Prade; Benoit Colsch; Marie-Laure Arcangeli; Thierry Leblanc; Arnaud Petit; Frederic Baleydier; Andre Baruchel; Judith Landman-Parker; Christophe Junot; Jerome Larghero; Paola Ballerini; Eric Delabesse; Benjamin Uzan; Francoise Pflumio
Journal:  Blood Adv       Date:  2017-09-08

2.  Allogeneic unrelated bone marrow transplantation from older donors results in worse prognosis in recipients with aplastic anemia.

Authors:  Yasuyuki Arai; Tadakazu Kondo; Hirohito Yamazaki; Katsuto Takenaka; Junichi Sugita; Takeshi Kobayashi; Yukiyasu Ozawa; Naoyuki Uchida; Koji Iwato; Naoki Kobayashi; Yoshiyuki Takahashi; Ken Ishiyama; Takahiro Fukuda; Tatsuo Ichinohe; Yoshiko Atsuta; Takehiko Mori; Takanori Teshima
Journal:  Haematologica       Date:  2016-02-08       Impact factor: 9.941

3.  Hypoxia favors chemoresistance in T-ALL through an HIF1α-mediated mTORC1 inhibition loop.

Authors:  Lucine Fahy; Julien Calvo; Sara Chabi; Laurent Renou; Charly Le Maout; Sandrine Poglio; Thierry Leblanc; Arnaud Petit; André Baruchel; Paola Ballerini; Irina Naguibneva; Rima Haddad; Marie-Laure Arcangeli; Frederic Mazurier; Francoise Pflumio; Benjamin Uzan
Journal:  Blood Adv       Date:  2021-01-26

Review 4.  Aberrant Signaling Pathways in T-Cell Acute Lymphoblastic Leukemia.

Authors:  Deborah Bongiovanni; Valentina Saccomani; Erich Piovan
Journal:  Int J Mol Sci       Date:  2017-09-05       Impact factor: 5.923

5.  [Risk-factors analysis of graft failure after allogeneic hematopoietic stem cell transplantation].

Authors:  Y Fei; X X Hu; Q Chen; A J Huang; H Cheng; X Ni; L Chen; L Gao; G S Tang; J Chen; W P Zhang; J M Yang; J M Wang
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2020-01-14

6.  Phospho-Specific Flow Cytometry Reveals Signaling Heterogeneity in T-Cell Acute Lymphoblastic Leukemia Cell Lines.

Authors:  Omar Perbellini; Chiara Cavallini; Roberto Chignola; Marilisa Galasso; Maria T Scupoli
Journal:  Cells       Date:  2022-06-29       Impact factor: 7.666

7.  Speed of leukemia development and genetic diversity in xenograft models of T cell acute lymphoblastic leukemia.

Authors:  Sandrine Poglio; Daniel Lewandowski; Julien Calvo; Aurélie Caye; Audrey Gros; Elodie Laharanne; Thierry Leblanc; Judith Landman-Parker; André Baruchel; Jean Soulier; Paola Ballerini; Emmanuelle Clappier; Françoise Pflumio
Journal:  Oncotarget       Date:  2016-07-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.